Delivery Order SPE2DB24D2100-SPE2DB25FBFUM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,257.50 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract was competitively awarded with no set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 15, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve as the point of performance for this pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,679.76 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 ml in D5W solution. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The delivery order was awarded...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,089.41 delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive award under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W (dextrose 5% in water) solution. This order, valued at $3,004.49, was competitively awarded on August 15, 2025, with a completion date of August 18, 2025. The contract utilizes firm fixed pricing and is classified as a non-set-aside award. Performance will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dobutamine 500 mg/250 ml in D5W solution. This firm fixed-price delivery order, valued at $2,139.28, is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $4,658.91 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes a firm fixed price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2024, for the supply of Dobutamine 500 mg/250 mL in D5W solution, with a contract value of $1,239.62 and ultimate completion date of November 5, 2024. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This non-set-aside, competitively awarded contract is valued at $2,881.19 with a firm fixed price structure and an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,282.48 to AmerisourceBergen Drug Corp for Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dobutamine 500 mg/250 mL in 5% dextrose solution with a ceiling value of $1,748.21. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFUMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units) under a firm fixed-price contract valued at $1,125.14. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order placed against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/12/25 |